Questions for Medicare in outbreak

APNewsBreak: Questions for Medicare in outbreak
In this May 15, 2012 file photo, Health and Human Services Secretary Kathleen Sebelius speaks in Bethesda, Md. Medicare, overseen by Sebelius' department, is coming under scrutiny in the meningitis outbreak that has rekindled doubts about the safety of the nation's drug supply. (AP Photo/Jose Luis Magana, File)

(AP)—Questions are being raised about Medicare in the meningitis outbreak that has rekindled doubts about the safety of the nation's drug supply.

The for seniors long ago flagged compounded drugs manufactured without oversight as safety risks. The outbreak that has sickened more than 250 people nationally has been linked to an injectable steroid from a Massachusetts compounding pharmacy.

In 2007, Medicare revoked coverage of compounded inhaler drugs for lung disease, citing safety reasons.

But Medicare doesn't seem to have consistently used its power to deny payment, and critics say that enables the compounding industry to flourish.

Sen. Charles Grassley says Medicare has some explaining to do. The Iowa Republican says every avenue for preventing another crisis must be explored.

Copyright 2012 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Citation: Questions for Medicare in outbreak (2012, October 19) retrieved 25 February 2024 from https://medicalxpress.com/news/2012-10-medicare-outbreak.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Look beyond drug makers to avoid tragedies like meningitis outbreak, expert says

 shares

Feedback to editors